Anti Vegf Injections | List of Frontiers open access articles

Original Research

Published on 12 Jul 2024

RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models

in Experimental Pharmacology and Drug Discovery

Uwe Grether
Richard H. Foxton
Sabine Gruener
Claudia Korn
Atsushi Kimbara
Anja Osterwald
Elisabeth Zirwes
Sabine Uhles
Janina Thoele
Nadine Colé

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426446

5,395 views
8 citations

Brief Research Report

Published on 14 Dec 2020

Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China

in Ophthalmology

Kai-Bo Yang
Hao Feng
Han Zhang

Frontiers in Medicine

doi 10.3389/fmed.2020.576275

5,187 views
37 citations

Review

Published on 28 Nov 2022

The effect of COVID-19 pandemic and wearing face masks on ophthalmology practice: What is known so far? A narrative review

in Ophthalmology

Luai Abu-Ismail
Khayry Al-Shami
Manar Al-Shami
Abdulqadir J. Nashwan

Frontiers in Medicine

doi 10.3389/fmed.2022.1019434

3,669 views
1 citation

Original Research

Published on 03 Jul 2025

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment

in Ophthalmology

Lulu Chen
Chuting Wang
Wenfei Zhang
Lihui Meng
Lu Sun
Youxin Chen

Frontiers in Medicine

doi 10.3389/fmed.2025.1565507

2,408 views

Original Research

Published on 19 Apr 2024

Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells

in Ophthalmic Drug Delivery

Madhuri Dandamudi
Peter McLoughlin
Gautam Behl
Lee Coffey
Anuj Chauhan
David Kent
Sweta Rani
Laurence Fitzhenry

Frontiers in Drug Delivery

doi 10.3389/fddev.2024.1337686

2,595 views

Original Research

Published on 10 Jul 2023

Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5

in Ophthalmology

Soo Chang Cho
Kyu Hyung Park
Sang Jun Park
Kwangsic Joo
Se Joon Woo

Frontiers in Medicine

doi 10.3389/fmed.2023.1204026

3,396 views
5 citations

Clinical Trial

Published on 11 Nov 2021

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up

in Ophthalmology

Yan Lu
Wenzhi Huang
Yuehong Zhang
Xiongfei Huang
Xu Zhang
Haizhi Ma
Guoliang Ren
Feng Shi
Lihui Kuang
Shigang Yan

Frontiers in Medicine

doi 10.3389/fmed.2021.735318

4,675 views
11 citations

Original Research

Published on 07 May 2021

Optical Coherence Tomography Angiography-Based Quantitative Assessment of Morphologic Changes in Active Myopic Choroidal Neovascularization During Anti-vascular Endothelial Growth Factor Therapy

in Ophthalmology

Yao Wang
Zhongli Hu
Tiepei Zhu
Zhitao Su
Xiaoyun Fang
Jijian Lin
Zhiqing Chen
Zhaoan Su
Panpan Ye
Jian Ma

Frontiers in Medicine

doi 10.3389/fmed.2021.657772

5,129 views
17 citations

Original Research

Published on 04 Jun 2025

Assessment of synthetic post-therapeutic OCT images using the generative adversarial network in patients with macular edema secondary to retinal vein occlusion

in Molecular and Cellular Pathology

Shi Feng
Jingyuan Yang
Xinyu Zhao
Jianchun Zhao
Yunfeng Du
Weihong Yu
Dayong Ding
Xirong Li
Youxin Chen

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1609567

1,371 views
1 citation

Articles

RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models

Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China

The effect of COVID-19 pandemic and wearing face masks on ophthalmology practice: What is known so far? A narrative review

Comparative outcomes of pars plana vitrectomy with subretinal rt-PA injection in polypoidal choroidal vasculopathy: the role of simultaneous anti-VEGF treatment

Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells

Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up

Optical Coherence Tomography Angiography-Based Quantitative Assessment of Morphologic Changes in Active Myopic Choroidal Neovascularization During Anti-vascular Endothelial Growth Factor Therapy

Assessment of synthetic post-therapeutic OCT images using the generative adversarial network in patients with macular edema secondary to retinal vein occlusion